Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review

Conclusions
The increasing use of CAR T therapy for malignancies underscores the importance of ophthalmologists and oncologists understanding the potential toxicities associated with its use, particularly ocular toxicities and when to refer for an ophthalmic examination.

Source: British Journal of Ophthalmology - June 22, 2023 Category: Opthalmology Authors: Mumtaz, A. A., Fischer, A., Lutfi, F., Matsumoto, L. R., Atanackovic, D., Kolanci, E. T., Hankey, K. G., Hardy, N. M., Yared, J. A., Kocoglu, M. H., Rapoport, A. P., Dahiya, S., Li, A. S., Sunshine, S. B. Tags: Original articles - Clinical science Source Type: research